Hear from Catalent's CEO on the evolving role of CDMOs & what’s next for Catalent

CDMOs’ Critical Role in a Rapidly

Evolving Biopharma Landscape

Date: Thursday, July 11th, 2024
Time: 11:00 AM EDT

It is an incredibly dynamic time for CDMOs. With increased awareness of the sector and its growing importance in the pharmaceutical supply chain, CDMOs have become broadly acknowledged as a critical part of the solution for meeting industry challenges, including accessing technologies and capacity, addressing regulatory complexity, and managing fixed costs and investments. Tune in to hear Catalent President and CEO Alessandro Maselli discuss these topics with Endpoints News founder John Carroll and the evolving role of CDMOs, and also touch on what’s next for Catalent, as it progresses with its shift from public to private ownership under its previously announced transaction with Novo Holdings.

Featured Speaker

Moderator

or call +1 877 891 9609 to speak with one of our experts today!

To unsubscribe or manage your subscriptions, please click here.

For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.

Catalent Pharma Solutions respects your privacy.

Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement of the website, its owner(s) or the content.

© 2024, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved.